
TPCera
Descripción de la empresa
Ver traducción
TPCera develops a new type of immunomodulatory compound that shifts the immune system from an inflammatory state into an anti-inflammatory one. The company is focused on shifting macrophages from M1 to M2, which has the potential to modulate autoimmune d...
HS code: {{pas.hsCode | limitTo: 23}}
Información comercial
Afiliaciones:
Personas en esta empresa (1)
Contact this company through Start-Up Nation Central
Para ponerse en contacto por favor envíe un email a soporte@connectamericas.com y en breve nos comunicaremos con usted.
Síguenos en